Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Sell
44
LVS Quote, Financials, Valuation and Earnings
Last price:
$41.14
Seasonality move
:
-0.98%
Day range:
$40.61 - $41.32
52-week range:
$30.18 - $56.61
Dividend yield:
2.19%
P/E ratio:
22.87x
P/S ratio:
2.67x
P/B ratio:
10.78x
Volume:
7.9M
Avg. volume:
6.5M
1-year change:
-6.45%
Market cap:
$29.1B
Revenue:
$11.3B
EPS (TTM):
$1.80
Analysts' Opinion
-
Consensus RatingLas Vegas Sands has received a consensus rating of Buy. The company's average rating is a Buy based on 12 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $51.13, Las Vegas Sands has an estimated upside of 24.22% from its current price of $41.16.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $43.00 representing -4.47% downside risk from its current price of $41.16.
Fair Value
-
According to the consensus of 16 analysts, Las Vegas Sands has 24.22% upside to fair value with a price target of $51.13 per share.
LVS vs. S&P 500
-
Over the past 5 trading days, Las Vegas Sands has overperformed the S&P 500 by 0.78% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Las Vegas Sands does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Las Vegas Sands revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Las Vegas Sands reported revenues of $2.9B.
Earnings Growth
-
Las Vegas Sands earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Las Vegas Sands reported earnings per share of $0.49.
Enterprise value:
40.2B
EV / Invested capital:
--
Price / LTM sales:
2.67x
EV / EBIT:
15.78x
EV / Revenue:
3.59x
PEG ratio (5yr expected):
0.75x
EV / Free cash flow:
34.04x
Price / Operating cash flow:
25.31x
Enterprise value / EBITDA:
10.16x
Gross Profit (TTM):
$5.4B
Return On Assets:
6.17%
Net Income Margin (TTM):
11.64%
Return On Equity:
36.71%
Return On Invested Capital:
7.49%
Operating Margin:
21.66%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $5.3B | $11.2B | $11.2B | $3B | $2.9B | |
| Gross Profit | $2.3B | $5.6B | $5.4B | $1.5B | $1.4B | |
| Operating Income | -$84M | $2.7B | $2.4B | $734M | $620M | |
| EBITDA | $1.1B | $4.3B | $4B | $1.1B | $1B | |
| Diluted EPS | -$0.72 | $2.07 | $1.80 | $0.66 | $0.49 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.6B | $6.7B | $7B | $5.6B | $3.7B | |
| Total Assets | $20.5B | $22.2B | $22.7B | $21.2B | $21.2B | |
| Current Liabilities | $2.5B | $2.1B | $3.9B | $4.3B | $6.3B | |
| Total Liabilities | $17.4B | $17.6B | $18.9B | $17.2B | $18.2B | |
| Total Equity | $3.2B | $4.7B | $3.8B | $4B | $3B | |
| Total Debt | $14.4B | $15B | $16B | $14B | $13.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $6M | $3.5B | $3B | $714M | $526M | |
| Cash From Investing | -$732M | -$1.3B | -$1.8B | -$200M | -$454M | |
| Cash From Financing | $911M | -$3.8B | -$3.1B | -$639M | -$692M | |
| Free Cash Flow | -$807M | $2.2B | $1.2B | $514M | $72M | |
LVS
Sector
Market Cap
$29.1B
$410.3M
Price % of 52-Week High
72.71%
71.02%
Dividend Yield
2.19%
0%
Shareholder Yield
8.62%
3.91%
1-Year Price Total Return
-6.46%
-13.51%
Beta (5-Year)
0.986
0.782
Dividend yield:
2.19%
Annualized payout:
$0.80
Payout ratio:
47.39%
Growth streak:
1 years
Technicals
8-day SMA
Buy
Level
$40.72
200-day SMA
Sell
Level
$44.61
Bollinger Bands (100)
Sell
Level
36.77 - 45.85
Chaikin Money Flow
Sell
Level
-126.8M
20-day SMA
Buy
Level
$40.71
Relative Strength Index (RSI14)
Buy
Level
57.54
ADX Line
Buy
Level
30.28
Williams %R
Neutral
Level
-43.4875
50-day SMA
Buy
Level
$37.91
MACD (12, 26)
Buy
Level
0.90
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Neutral
Level
1.4B
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.383)
Sell
CA Score
(Annual)
Level (-1.2239)
Buy
Beneish M-Score
(Annual)
Level (-2.8889)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (1.1401)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, the company generates all its EBITDA from Asia, with its casino operations generating the majority of sales.
Stock Forecast FAQ
In the current month, LVS has received 12 Buy ratings 4 Hold ratings, and 0 Sell ratings. The LVS average analyst price target in the past 3 months is $51.13.
-
Where Will Las Vegas Sands Stock Be In 1 Year?
According to analysts, the consensus estimate is that Las Vegas Sands share price will rise to $51.13 per share over the next 12 months.
-
What Do Analysts Say About Las Vegas Sands?
Analysts are divided on their view about Las Vegas Sands share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Las Vegas Sands is a Sell and believe this share price will drop from its current level to $43.00.
-
What Is Las Vegas Sands's Price Target?
The price target for Las Vegas Sands over the next 1-year time period is forecast to be $51.13 according to 16 Wall Street analysts, 12 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is LVS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Las Vegas Sands is a Buy. 12 of 16 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of LVS?
You can purchase shares of Las Vegas Sands via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Las Vegas Sands shares.
-
What Is The Las Vegas Sands Share Price Today?
Las Vegas Sands was last trading at $41.14 per share. This represents the most recent stock quote for Las Vegas Sands. Yesterday, Las Vegas Sands closed at $41.16 per share.
-
How To Buy Las Vegas Sands Stock Online?
In order to purchase Las Vegas Sands stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
